News
10h
Vietnam Investment Review on MSNInnovent Showcases Breakthrough Preclinical Data on Novel Antibodies at AACR 2025SAN FRANCISCO and SUZHOU, China, April 28, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
The company will also present a poster on randomized Phase II data of TG4001 in combination with avelumab in the cervical cancer subgroup. The 2025 American Society of Clinical Oncology (ASCO), annual ...
Radiant Biotherapeutics, a preclinical biotechnology company developing an antibody platform to deliver first-in-class transformative therapies for patients facing life-changing disease, today ...
Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced that its partner, Pfizer, has presented preclinical data on PF-08052666 ...
Financial markets evolve at breakneck speed, making access to cutting-edge analysis and real-time insights the definitive line between success and missed opportunities. FintechZoom.com has emerged as ...
This endeavour seeks to offer a more nuanced, responsible, and humane approach to shaping our built environments ...
Researchers with City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U ...
Putting the pieces of the puzzle together for yourself is very rewarding. As show by these 10 Best Games That Don't ...
One particularly charming corner of the store is dedicated to vintage toys and games – tin wind-up figures, hand-carved ...
Located conveniently off I-70 about 150 miles west of Kansas City, Abilene sits at that perfect sweet spot for family travel ...
While the decision to have a poster presentation at 2025 ASCO® was based on the limited data included in the submitted abstract ... of our proprietary technology; our patents may be found ...
While the decision to have a poster presentation at 2025 ASCO® was based on the limited data included in the submitted abstract, we are very much looking ... protection of our proprietary technology; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results